Searched for
CADILA EARNINGS
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Cadila Healthcare Q3 Results: Firm posts 5% decline in profit at Rs 500 crConsolidated total revenue from operations stood at Rs 3,655 crore during the quarter under review as compared to Rs 3,633 crore in the yea...
- Motilal Oswal has a buy on Cadila Healthcare, target price Rs 420After exhibiting year on year earnings decline in FY20, the brokerage expects Cadila’s earnings to be back on the growth path.
- Trending stocks: Cadila Healthcare shares flat ahead of Q4 resultsA total of 28,973 shares changed hands on the counter till 10:36AM (IST).
- Buy Cadila Healthcare, target Rs 315: Nirmal Bang SecuritiesCadila Healthcare is a largecap company, operating in pharmaceuticals and health care sector.
- Buy Cadila Healthcare, target Rs 444: Equirus SecuritiesBuy Cadila Healthcare Ltd. at a price target of Rs 444.0 .
- CLSA upgrades Cadila Healthcare to 'buy'Shares of Cadila ended down 1.74 per cent at Rs 369.95 on the BSE on Friday.
- Pankaj Patel owned Cadila ups its India game with AZ’s brandsAs part of the agreement, AZ will sell the following brands of Bricarex, Bricarex-A, Bricanyl, Xylocard, Ceriviprime, Prostodin, Partocin a...
- Outperform Cadila Healthcare Ltd., target Rs 405: Credit SuisseThe June quarter results are likely to remain weak given competition in HCQS, lower share in key drugs. Once Moraiya is cleared, Cadila sho...
- Underperform on Cadila Healthcare with a target at Rs 346: CLSAThe pricing pressure in the key US product, HCQS has started to show up which will weigh on the stock. HCQS could see further price decline...
- Cadila Healthcare Q1 net up 23.14% at Rs 240.21 croreThe company had reported a net profit of Rs 195.06 crore in the April-June quarter of financial year 2013-14.
- Cadila valuations healthy as US generics biz takes offCadila has built a strong pipeline of products —136 new drug applications pending for approval — 19 first-to-file drug approvals and author...
- Cadila Healthcare Q1 profit up 1.33%Cadila Healthcare today reported 1.33 per cent increase in net profit at Rs 203.61 crore for the quarter ended June 30, 2013.
- Cadila Health Q3 net dips 31% at Rs 102.91 croreCadila Healthcare today reported 31.03 per cent dip in consolidated net profit to Rs 102.91 crore for its third quarter ended December 31.
- Broker's call: Cadila HealthcareCredit Suisse has initiated coverage on Cadila Healthcare with an ‘Outperform’ rating with a target price of Rs 970 with a 21.4% upside.
- Cadila Healthcare Q4 net zooms by 50.69 pc to Rs 178.97 crCadila Healthcare today said its consolidated net profit rose by 50.69 per cent to Rs 178.97 crore for the fourth quarter ended March 31, 2...
- Cadila Healthcare Q2 net up 29.49% to Rs 170.8 crDrug firm Cadila Healthcare today said its consolidated net profit rose by 29.49 per cent to Rs 170.8 crore for the second quarter ended Se...
- Cadila Healthcare Q1 net jumps 60 pc to Rs 199 crCadila Healthcare on Tuesday posted a 60 per cent growth in net profit to Rs 199.18 crore for the quarter ended June 30.
Load More
